Epidemiology

  • Most commonly affects individuals from the Mediterranean region to eastern Asia, with the highest prevalence observed in Turkey and Japan

Etiology

  • Possible autoimmune and infectious triggers (e.g., precipitating HSV or parvovirus infection)
  • Strong HLA-B51 association

Pathophysiology

  • Autoimmune systemic vasculitis that can involve arteries and veins of all sizes
  • Characterized by the deposition of immune complexes, proliferation of CD4+ T cells, and increased cytokines

Clinical features

  • Recurrent painful oral aphthous ulcers (95–100%)
    • Typically the initial presenting symptom
    • Usually last about 1–4 weeks
  • Recurrent genital ulcerations (60–90%)
  • Ocular disease (50–80%)
    • Uveitis (iridocyclitis, chorioretinitis), keratitis, and/or retinal vasculitis
  • Skin lesions (35–85%)
    • Erythema nodosum
    • Positive pathergy skin test: the appearance of an erythematous papule or pustule 48 hours after a 5 mm skin prick with a 20-gauge needle (usually on the forearm)
      • The main reason is subcutaneous vasculitis and high sensitivity reaction of the skin.
  • Arthritis (30–70%)

Mnemonic

PATHERGY: Positive pathergy test, Aphthous oral ulcers, Thrombosis (arterial and venous), Hemoptysis (pulmonary artery aneurysm), Eye lesions (uveitis, retinal vasculitis), Recurrent Genital ulcers, Young at presentation (3rd decade)


Diagnostics

Pasted image 20231015171653.png


Treatment